CGON
Price
$52.56
Change
+$8.10 (+18.22%)
Updated
Feb 3 closing price
Capitalization
4.34B
51 days until earnings call
Intraday BUY SELL Signals
IMVT
Price
$25.80
Change
+$8.32 (+47.60%)
Updated
Feb 3 closing price
Capitalization
5.2B
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs IMVT

Header iconCGON vs IMVT Comparison
Open Charts CGON vs IMVTBanner chart's image
CG Oncology
Price$52.56
Change+$8.10 (+18.22%)
Volume$1.34M
Capitalization4.34B
Immunovant
Price$25.80
Change+$8.32 (+47.60%)
Volume$981.03K
Capitalization5.2B
CGON vs IMVT Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
IMVT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. IMVT commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Buy and IMVT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (CGON: $52.56 vs. IMVT: $25.80)
Brand notoriety: CGON and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 116% vs. IMVT: 58%
Market capitalization -- CGON: $4.34B vs. IMVT: $5.2B
CGON [@Biotechnology] is valued at $4.34B. IMVT’s [@Biotechnology] market capitalization is $5.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while IMVT’s TA Score has 3 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 5 bearish.
  • IMVT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CGON is a better buy in the short-term than IMVT.

Price Growth

CGON (@Biotechnology) experienced а -4.61% price change this week, while IMVT (@Biotechnology) price change was -3.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

CGON is expected to report earnings on Mar 27, 2026.

IMVT is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($5.2B) has a higher market cap than CGON($4.34B). CGON YTD gains are higher at: 26.590 vs. IMVT (1.495). CGON has higher annual earnings (EBITDA): -179.53M vs. IMVT (-486.69M). CGON has more cash in the bank: 680M vs. IMVT (522M). IMVT has less debt than CGON: IMVT (98K) vs CGON (7.24M). CGON has higher revenues than IMVT: CGON (2.17M) vs IMVT (0).
CGONIMVTCGON / IMVT
Capitalization4.34B5.2B84%
EBITDA-179.53M-486.69M37%
Gain YTD26.5901.4951,779%
P/E RatioN/AN/A-
Revenue2.17M0-
Total Cash680M522M130%
Total Debt7.24M98K7,389%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONIMVT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 6 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 29 days ago
76%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
IMVT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBHVX16.720.26
+1.58%
Segall Bryant & Hamill Sm Cp Val Ins
GSINX23.540.22
+0.94%
Goldman Sachs GQG Ptnrs Intl Opps Inv
JISCX25.070.19
+0.76%
Janus Henderson Small Cap Value S
RGREX9.430.05
+0.53%
Invesco Global Real Estate R
TSRLX82.49-1.12
-1.34%
Touchstone Large Cap Focused R6

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-3.28%
IDYA - CGON
57%
Loosely correlated
+0.50%
ACLX - CGON
54%
Loosely correlated
-0.01%
SYRE - CGON
53%
Loosely correlated
+1.65%
NUVL - CGON
53%
Loosely correlated
+2.12%
BHVN - CGON
52%
Loosely correlated
-3.06%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-1.07%
ROIV - IMVT
62%
Loosely correlated
+0.14%
IDYA - IMVT
56%
Loosely correlated
+0.50%
NUVL - IMVT
55%
Loosely correlated
+2.12%
DNLI - IMVT
54%
Loosely correlated
-4.22%
CGON - IMVT
54%
Loosely correlated
-3.28%
More